Joint effects of hypertension, smoking, dyslipidemia and obesity and angiotensin-converting enzyme DD genotype on albuminuria in Taiwanese patients with type 2 diabetes mellitus

Clinical Biochemistry
Chin-Hsiao TsengChoon-Khim Chong

Abstract

We investigated the individual and joint effects of hypertension, smoking, dyslipidemia, and obesity and angiotensin-converting enzyme (ACE) DD genotype on albuminuria in Taiwanese type 2 diabetic patients. ACE genotypes were determined in 519 (287 men and 232 women) patients aged 58.5 (SD: 9.0) years. Among them, 240 had albuminuria (urinary albumin-to-creatinine ratio > or =30 microg/mg). Logistic regression was used to evaluate the individual and joint effects of risk factors and DD classified by two-by-four table. The adjusted odds ratios were significant for hypertension, smoking and obesity but not for DD and dyslipidemia in models evaluating individual effects. However, while analyzing the joint effects of DD and hypertension, smoking, dyslipidemia and obesity, the respective adjusted odds ratios were 3.253 (1.261-8.391), 3.016 (1.086-8.376), 2.385 (1.010-5.630) and 2.508 (1.117-5.631). Hypertension, smoking, dyslipidemia and obesity jointly play an important role with DD genotype in mediating albuminuria.

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Mar 16, 1995·The New England Journal of Medicine·K LindpaintnerC H Hennekens
Oct 1, 1995·Journal of Diabetes and Its Complications·S PanagiotopoulosG Jerums
Sep 4, 1998·Journal of the American Society of Nephrology : JASN·W GrzeszczakE Zukowska-Szczechowska
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·B Agerholm-LarsenA Tybjaerg-Hansen
Jun 1, 2001·American Journal of Epidemiology·L D Botto, M J Khoury
Jun 14, 2003·Stroke; a Journal of Cerebral Circulation·Fakhredin A Sayed-TabatabaeiJacqueline C M Witteman
Jul 23, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·S HadjadjUNKNOWN DIABHYCAR Study Group
Sep 15, 2004·Experimental & Molecular Medicine·H Arzu ErgenTurgay Isbir
Jan 7, 2005·Journal of Medical Genetics·F A Sayed-TabatabaeiC M van Duijn
Jan 19, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C-H Tseng
Jun 26, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Chin-Hsiao Tseng
Jan 18, 2008·Journal of the American Society of Nephrology : JASN·Hans-Henrik ParvingBarry M Brenner
Apr 12, 2008·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Imen ArfaSonia Abdelhak
Apr 17, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Michael Bader, Detlev Ganten
May 31, 2008·American Journal of Epidemiology·Guang Yong Zou
Aug 30, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Chin-Hsiao TsengTong-Yuan Tai

❮ Previous
Next ❯

Citations

Nov 16, 2010·Cardiology Research and Practice·Chin-Hsiao Tseng
Sep 12, 2013·PloS One·Xiao-feng WangWei-jian Guo
Nov 22, 2012·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Chin-Hsiao Tseng, Farn-Hsuan Tseng
Aug 19, 2020·International Journal of Environmental Research and Public Health·Paweł WańkowiczIwona Rotter

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.